Vairavan Latha 4
4 · Arcutis Biotherapeutics, Inc. · Filed May 6, 2026
Research Summary
AI-generated summary of this filing
Arcutis (ARQT) CFO Vairavan Latha Sells 1,341 Shares
What Happened
CFO Vairavan Latha reported a sale of 1,341 shares of Arcutis Biotherapeutics common stock on May 4, 2026. The filing shows a weighted-average sale price of $23.61, for total proceeds of approximately $31,662. The Form 4 indicates the sale was to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
Key Details
- Transaction date: 2026-05-04 (reported on Form 4 filed 2026-05-06) — filed within the typical 2-business-day window for Form 4s.
- Transaction type: Sale (S) — reported as open market/private sale; sale was for tax withholding (Footnote F1).
- Price: weighted-average $23.61; shares sold in multiple trades at prices ranging $23.16 to $23.93 (Footnote F2). Reporting person offers to provide per-price breakdown on request.
- Shares sold: 1,341; proceeds ≈ $31,662.
- Shares owned after transaction: Not disclosed in this filing.
Context
This sale was a tax-withholding sale tied to RSU vesting, a common and routine form of insider sale that does not necessarily indicate a change in the insider’s view of the company. No options were exercised and no 10b5-1 plan or late filing is indicated in this Form 4.
Insider Transaction Report
Form 4
Vairavan Latha
SVP Chief Financial Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-05-04$23.61/sh−1,341$31,662→ 86,413 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.16 to $23.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Signature
/s/ Masaru Matsuda, as Attorney-in-Fact for Latha Vairavan|2026-05-06